Friday, April 5

• 3:00 p.m. – 4:30 p.m. | Educational Session: Measuring Structural and Social Determinants of Health in Cancer Research
  Salma Shariff-Marco, PhD, MPH, a social and behavioral scientist and UCSF associate adjunct professor, serves as chairperson of this session and also presents “Characterizing social and built environments in cancer epidemiology cohorts: Geospatial data and methods.” 

Saturday, April 6

• 2:30 p.m. – 4:00 p.m. | Educational Session: “Genetic Ancestry, Tumor Subtype and Somatic Genomic Landscape”
  Elad Ziv, MD, an internal medicine specialist and UCSF professor of Medicine, presents “Genetic ancestry and somatic mutational landscape in >40,000 breast cancer patients.” 

Sunday, April 7

• 1:00 p.m. – 2:30 p.m. | Major Symposium: Socioeconomic Contributions to Cancer Health Disparities
  Scarlett Gomez, MPH, PhD, an epidemiologist and UCSF professor of Epidemiology and Biostatistics, serves as chairperson for the symposium and also presents “Multi-level socioeconomic contributions to cancer health disparities from concept to measurement to practice."
   
• 3:00 p.m. – 5:00 p.m. | Mini-Symposium: CL01.03 - Biomarkers Predictive of Therapeutic Benefit
  Denise Wolf, PhD, UCSF Department of Laboratory Medicine, is the presenter for “Immune subtyping identifies a subset of HR+HER2- early-stage breast cancer patients with a very high likelihood of response to neoadjuvant immunotherapy (IO): Results from 5 IO arms of the I-SPY2 TRIAL.” 
   
• 6:50 – 7:40 p.m. | Artificial Intelligence for Research Enhancement in Population Sciences: A Population Sciences Working Group Town Hall Meeting
  Yulin Hswen, PsyD, MPH, is a computational epidemiologist and assistant professor in the Department of Epidemiology and Biostatistics and the Bakar Computational Health Sciences Institute at UCSF, where she leads research on using artificial intelligence to uncover social patterns of disease and the transmission of information through social networks. 

Monday, April 8

• 10:15 a.m. – 12:00 a.m. | Presidential Select Symposium: Cancer Immunotherapy – Where Do We Go from Here?
  Alexander Marson, MD, PhD, UCSF professor of Medicine and director of the Gladstone-UCSF Institute of Genomic Immunology, will present “Decoding and reprogramming T-cell circuits with CRISPR” at the presidential select symposium.
   
• 10:15 a.m. – 12:15 p.m. |  Clinical Trials Plenary Session: Advances in Targeted Therapy
  Hope Rugo, MD, a medical oncologist, Winterhof Family Endowed Professorship in Breast Cancer, and director of Breast Oncology Trials and Clinical Education at UCSF, will be a discussant for two UK trials called the Partner trials. 
   
• 10:15 a.m. – 11:45 a.m. | Major Symposium: Advances in Pediatric Cancer: Mechanisms, Vulnerabilities, and TranslationAlejandro Sweet-Cordero, MD, UCSF chief of Pediatric Oncology, presents “Identification of novel osteosarcoma subtypes based on epigenetic and genomic analysis.” 
  
  Sweet-Cordero also will serve as chairperson for Town Hall Meeting: Then and Now: Updates in Pediatric Cancer Predisposition— A Pediatric Cancer Working Group Town Hall Meeting on Sunday, April 7, from 6:00 p.m. – 8:30 p.m.  He is chair of AACR’s Pediatric Cancer Working Group (PCWG).
   
• 2:30 p.m. - 4:30 p.m. | Mini-symposium: Novel Molecular Targets and Biomarkers
  Darwin Kwok, MS, cancer immunotherapy Ph.D. candidate at UCSF, presents “Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types.” 
   
• 5:00 p.m. – 5:45 p.m. | “Meet-the-Expert” session
  Jennifer Ruben Grandis, MD, an otolaryngologist and associate vice chancellor for clinical and translational research at UCSF, leads a “meet the expert session” on the topic of “Identifying and Measuring Gender Inequities in Science and Medicine.” 

Tuesday, April 9

• 10:15 a.m. – 11:45 a.m. | Major Symposium: Health Behavior Practices after Cancer Diagnosis to Deter Cancer Progression and Death: Evidence, Gaps, and Solutions
  June Chan, ScD, the Steven and Christine Burd-Safeway Distinguished Professor of Epidemiology and Biostatistics at UCSF, serves as chairperson for this symposium and presents “Does exercise or fitness deter cancer progression after diagnosis?”
   
• 12:30 p.m. – 2:00 p.m. |  Advances in Diagnostics and Therapeutics session: KRAS: Broadening the Attack Beyond G12C with Small Molecules and Immuno-Oncology
  Kevin M. Shokat, PhD, UCSF professor of Cellular and Molecular Pharmacology and AACR Academy Fellow, chairs this session and presents “Expanding K-Ras covalent chemistry for targeting K-Ras (G12D).” 
   
• 12:30 p.m. – 2:00 p.m. | Major Symposium: Discovering and Broadening the Therapeutic Modalities of Immune Therapy
  Matthew Krummel, PhD, professor of Pathology and Robert E. Smith Endowed Chair in Experimental Pathology at UCSF, presents “Using archetypes and machine learning to discover novel immune pathways for tumor elimination.”
   
• 12:30 p.m. – 2:00 p.m. | Advances in Prevention Research session: “From Precursors to Prevention: How Research into Cancer Precursor Lesions Creates Prevention Opportunities”Boris Bastian, MD, PhD a dermatologist and the Gerson and Barbara Bass Bakar Distinguished Professor in Cancer Research at UCSF, presents “When you come to a fork in the road, take it: Navigating the diverse evolutionary paths from precursor lesions to melanomas.”
   
• 6:00 p.m. – 8:00 p.m. | Town Hall Meeting: Advancing Radiation Oncology with Artificial Intelligence: A Radiation Science and Medicine Working Group Town Hall Meeting
  Gilmer Valdes, PhD, assistant professor in the UCSF department of Radiation Oncology, is an invited speaker presenting “Causal Targeted Machine Learning for Real-World Evidence Generation in Oncology: Assessing Causal Effects of Radiation Toxicity on Overall Survival in Stage III Non-Small Cell Lung Cancer.” 

Wednesday, April 10

• 10:15 a.m. – 11:45 a.m.  | Major Symposium: Cancer Metabolism Across Scales: From Organelles to Organisms
  Rushika Perera, PhD, UCSF associate professor of Anatomy, presents “Lysosome dependent metabolic adaptation in pancreatic cancer.”